HighTower Advisors’s Dare Bioscience DARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-900
| Closed | -$5K | – | 3394 |
|
|
2024
Q1 | $5K | Sell |
900
-2,992
| -77% | -$16.6K | ﹤0.01% | 3298 |
|
|
2023
Q4 | $14K | Buy |
3,892
+3,000
| +336% | +$10.8K | ﹤0.01% | 3319 |
|
|
2023
Q3 | $5K | Hold |
892
| – | – | ﹤0.01% | 3296 |
|
|
2023
Q2 | $10K | Sell |
892
-500
| -36% | -$5.61K | ﹤0.01% | 3222 |
|
|
2023
Q1 | $17K | Sell |
1,392
-333
| -19% | -$4.07K | ﹤0.01% | 3075 |
|
|
2022
Q4 | $17K | Sell |
1,725
-445
| -21% | -$4.39K | ﹤0.01% | 3056 |
|
|
2022
Q3 | $26K | Sell |
2,170
-3,000
| -58% | -$35.9K | ﹤0.01% | 2887 |
|
|
2022
Q2 | $76K | Buy |
5,170
+2,667
| +107% | +$39.2K | ﹤0.01% | 2808 |
|
|
2022
Q1 | $45K | Buy |
2,503
+614
| +33% | +$11K | ﹤0.01% | 3023 |
|
|
2021
Q4 | $45K | Buy |
1,889
+53
| +3% | +$1.26K | ﹤0.01% | 2964 |
|
|
2021
Q3 | $36K | Sell |
1,836
-667
| -27% | -$13.1K | ﹤0.01% | 2915 |
|
|
2021
Q2 | $57K | Buy |
2,503
+1,167
| +87% | +$26.6K | ﹤0.01% | 2833 |
|
|
2021
Q1 | $27K | Sell |
1,336
-1,334
| -50% | -$27K | ﹤0.01% | 2810 |
|
|
2020
Q4 | $42K | Buy |
2,670
+667
| +33% | +$10.5K | ﹤0.01% | 2340 |
|
|
2020
Q3 | $24K | Sell |
2,003
-167
| -8% | -$2K | ﹤0.01% | 2284 |
|
|
2020
Q2 | $26K | Buy |
2,170
+834
| +62% | +$9.99K | ﹤0.01% | 2179 |
|
|
2020
Q1 | $14K | Buy |
+1,336
| New | +$14K | ﹤0.01% | 2038 |
|